VA Pittsburgh Healthcare System, Infectious Diseases Section, Pittsburgh, Pennsylvania, USA
VA Pittsburgh Healthcare System, Infectious Diseases Section, Pittsburgh, Pennsylvania, USA.
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01011-20.
There are scant data on the impact of coronavirus disease 2019 (COVID-19) on hospital antibiotic consumption, and no data from outside epicenters. At our nonepicenter hospital, antibiotic days of therapy (DOT) and bed days of care (BDOC) were reduced by 151.5/month and 285/month, respectively, for March to June 2020 compared to 2018-2019 (0.001 and 0.001). DOT per 1,000 BDOC was increased (8.1/month; 0.001). COVID-19 will impact antibiotic consumption, stewardship, and resistance in ways that will likely differ temporally and by region.
关于 2019 年冠状病毒病（COVID-19）对医院抗生素使用的影响，数据很少，而且没有来自非震中地区的数据。在我们的非震中医院，与 2018-2019 年相比，2020 年 3 月至 6 月，抗生素治疗日（DOT）和病床日护理（BDOC）分别减少了 151.5/月和 285/月（0.001 和 0.001）。每 1000 个 BDOC 的 DOT 增加（8.1/月；0.001）。COVID-19 将以可能在时间和区域上有所不同的方式影响抗生素的使用、管理和耐药性。
